What Your Clients Actually Want From the Devices You Stock

When it comes to investing in devices for the treatment menu, most salons and clinics are guessing. The decision usually comes down to gut feel, a strong supplier pitch, and a glance at what the clinic down the road is offering. The actual client (the one who'll sit in the chair and decide whether to rebook) rarely gets a vote in the buying process.

So when proper data lands telling us what clients actually want from a device-based treatment, it's worth pausing on. This set is from Kantar Market Research on file with Acclaro Medical, ranking the highest motivating factors that lead clients to choose a device-based treatment. Here's the data.

What clients said they want most

• Little to no pain — 43%

• FDA-cleared — 35%

• Only takes 15 minutes — 35%

• Reduces fine lines and wrinkles — 33%

• Little to no downtime — 26%

• Makes my skin feel smooth — 25%

• Stimulates collagen — 25%

• Clears sunspots on my skin — 22%

• Causes my skin to exfoliate — 17%
  

Now, let's talk about what this list is actually telling us.

Clients are buying experience, not science

The single highest-ranked factor (by a margin of eight percentage points) is "little to no pain." Not efficacy, technology or the brand - comfort.

Tied for second are regulatory credibility and treatment duration. Both 35%. Both about trust and convenience rather than the actual outcome.

The first result-based motivator ("reduces fine lines and wrinkles") comes in fourth at 33%. The mechanism-of-action language that device manufacturers love (stimulates collagen, exfoliates, clears pigmentation) sits between 17% and 25%.

So when a clinic owner is sitting in a device demo being walked through wavelengths, fluence settings, treatment depths and clinical study outcomes, the things that will actually drive client uptake of that device are barely in the conversation.

The decision to book (and rebook) is being made on pain tolerance, treatment time, and whether the client trusts that the device is legitimate.

This isn't a knock on clinical efficacy. Of course efficacy matters. It's the foundation of everything. But efficacy on its own doesn't sell a course of treatments. Comfort, time, and credibility do.

What this means when you're choosing what to stock

If you're a salon or clinic owner weighing up your next device investment, this data should reframe the questions you're asking the supplier.

Most device pitches lead with technology and outcomes. The questions that actually predict whether your clients will love the treatment look more like this:

• What does the client physically feel during the treatment? Not "is it tolerable" — what is the actual sensation, and how would I describe it on a treatment menu?

• How long is the treatment, chair to chair? Not just the active time — the prep, the post-care application, the cool-down. The 15-minute appointment is the magic number in this data.

• What's the realistic downtime? And what does it actually look like — pinkness, flaking, swelling? Can a client go back to work the next day?

• What's the regulatory status in Australia? Is it on the ARTG? What classification?

• What's the rebooking rate among clinics already running this device?
  

That last one is the most underused question in the device buying process. Suppliers love to talk clinical outcomes and treatment protocols. The clinics already using the device can tell you whether clients book a second session.

What this means for how you market a device once you have it

Here's where most clinics leave money on the table. They get the device, they invest in the training, and then they market it the way the supplier markets it — with clinical language, mechanism-of-action explanations, and before-and-after grids.

That language works for the 25% of clients motivated by collagen stimulation. It does not land for the 43% motivated by pain levels.

The data points to a different content strategy:

• Lead with the felt experience. "Warm, tingly, like a hot stone facial" sells better than "fractional ablative resurfacing."

• Make the time commitment hero. Fifteen minutes is a coffee break. That positioning matters.

• Talk openly about regulation. Clients want to know it's legitimate. Naming the ARTG listing or relevant clearance in plain English on your website builds trust without sounding clinical.

• Talk about downtime honestly. Hiding the redness in your before-and-afters costs you trust. Naming it — and showing the day three, day five, day seven recovery — earns it.

• Save the mechanism-of-action language for clients who ask. It's a credibility layer for the curious, not a headline for the hesitant.
  

The harder takeaway

The thing this slide doesn't say out loud is that clients don't really need to understand how a device works. They need to trust that it does, that it won't hurt, that it won't ruin their week, and that it's been checked by someone whose job it is to check.

That's a less satisfying truth for an industry that has spent the last decade getting more technical, more clinical, more device-led. But it's also a permission slip. You don't need to teach your clients photobiology before they'll book in. You need to tell them what it feels like, how long it takes, what they'll look like afterwards, and why the device is trusted.

Stock and market for that. The technology will do its job in the background.

Source: Kantar Market Research on file with Acclaro Medical.